Comparative Insight of Regulatory Guidelines for Probiotics in USA, India and Malaysia: A Critical Review
DOI:
https://doi.org/10.6000/1927-3037.2013.02.02.1Keywords:
Dietary supplements, Functional food, Lactobacillus, Probiotics, Regulatory guidelines, FDAAbstract
Probiotics have always been a unique category of natural products due to established evidences of their applications in wellness of human beings. Inspite of being based on live microorganisms, commercial exploration of probiotics as biologics, pharmaceuticals, food and nutritional supplements has witnessed a tremendous increase due to their potential of providing health benefits. Currently different regulatory bodies across the globe consider probiotics under several categories depending upon their intended use. In order to clear the ambiguity related to regulatory specifications, assurance of quality and premarketing safety assessment for drafting of comprehensive guidelines with global acceptance is need of the hour. The aim of this paper is to compare existing regulations in countries like United States, India and Malaysia to develop harmonized guidelines for approval of probiotics.
References
Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol 1998; 39: 237-38. http://dx.doi.org/10.1016/S0168-1605(97)00136-0
O’Sullivan MG, Thornton GM, O’Sullivan GC, Collins JK. Probiotic bacteria: myth or reality? Trends Food Sci Technol 1992; 3: 309-14. http://dx.doi.org/10.1016/S0924-2244(10)80018-4
Venugopalan V, Shriner KA, Wong-Beringer A. Regulatory oversight and safety of probiotic use. Emerg Infect Dis 2010; 16: 1661-65. http://dx.doi.org/10.3201/eid1611.100574
Sanders M, Gibson G, Gill HS. Probiotics: Their Potential to Impact Human Health. CAST issue paper 2007; pp. 1-20.
Degnan FH. The US Food and Drug Administration and Probiotics: Regulatory Categorization. Clin Infect Dis 2008; 46: S133-36. http://dx.doi.org/10.1086/523324
Kumar M, Kumar R, Poovai PD, Kalaichelvan PT. Probiotics and multitude of health benefits. J Res Bio 2012; 2: 102-13.
Parvez S, Malik KA, Kang AH, Kim HY. Probiotics and their fermented food products are beneficial for health. J App Microbio 2006; 100: 1171-85. http://dx.doi.org/10.1111/j.1365-2672.2006.02963.x
Savaiano DA, Abou EA, Smith DE, Levitt MD. Lactose malabsorption from yogurt, sweet acidophilus milk, and cultured milk in lactose deficient individuals. Am J Clin Nutr 1984; 40: 1219-23.
Devrese M, Stegelmann A, Richter B, Fenseau S, Love C, Schrezenneir J. Probiotics compensation for lactose insufficiency. Am J Clin Nutr 2001; 73: 421-29.
Kim HS, Gilliland SE. Lactobacillus acidophilus as dietary adjunct for milk to aid lactose digestion in humans. J Dairy Sci 1983; 66: 959-66. http://dx.doi.org/10.3168/jds.S0022-0302(83)81887-6
Kolars JC, Levitt MD, Aouj M, Savaino DA. Yogurt-an antidigesting source of lactose. N Engl J Med 1984; 310: 1-3. http://dx.doi.org/10.1056/NEJM198401053100101
Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhea. Cochrane Database Syst Rev 2003; 2: CD003048. http://dx.doi.org/10.1002/14651858.CD003048.pub3
Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000; 30: 54-60. http://dx.doi.org/10.1097/00005176-200001000-00018
Shornikova AV, Isolauri E, Burkanova L, Lukovnikova S, Vesikari T. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhea. Acta Paediatr 1997; 86: 460-65. http://dx.doi.org/10.1111/j.1651-2227.1997.tb08913.x
Pant AR, Graham SM, Allen SJ, et al. Lactobacillus GG and acute diarrhea in young children in the tropics. J Trop Pediatr 1996; 42: 162-65. http://dx.doi.org/10.1093/tropej/42.3.162
Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J 1995; 14: 107-11. http://dx.doi.org/10.1097/00006454-199502000-00005
Sepp E, Tamm E, Torm S, Lutsar I, Mikelsaar M, Salminen S. Impact of a Lactobacillus probiotic on the faecal microflora in children with shigellosis. Microecol Ther 1995; 23: 74-80.
Szajewska H, Kotowska M, Murkowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001; 138: 361-65. http://dx.doi.org/10.1067/mpd.2001.111321
Mastretta E, Longo P, Laccisaglia A, et al. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 2002; 35: 527-31. http://dx.doi.org/10.1097/00005176-200210000-00013
Oberhelman RA, Gilman RH, Sheen P, et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 1999; 134: 15-20. http://dx.doi.org/10.1016/S0022-3476(99)70366-5
Shornikova AV, Cosas I, Mykkanen H, Salo E, Vesikari T. Bactiotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 1997; 16: 1103-7. http://dx.doi.org/10.1097/00006454-199712000-00002
Cetina-Sauri G, Sierra Basto G. Evaluation therapeutique de Saccharomyces boulardii chez des enfants souffrant de diarrhee aigue. Ann Pediatr 1994; 41: 397-400.
Ho¨chter W, Chase D, Hegenhoff G. Saccharomyces boulardii in treatment of acute adult diarrhoea: efficacy and tolerance of treatment. Mu¨nch Med Wochen 1990; 132: 188-92.
Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104: e64. Available from: http://pediatrics.aappublications. org/content/104/5/e64.full.html
Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999; 135: 564-68. http://dx.doi.org/10.1016/S0022-3476(99)70053-3
Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001; 63: 1-7. http://dx.doi.org/10.1159/000051865
Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97: 2744-49. http://dx.doi.org/10.1111/j.1572-0241.2002.07063.x
Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15: 163-69. http://dx.doi.org/10.1046/j.1365-2036.2001.00923.x
Siitonen S, Vapaatalo H, Salminen S, et al. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhea. Ann Med 1990; 22: 57-59.
Marchand J, Vandenplas Y. Microorganisms administered in the benefit of the host: myths and facts. Eur J Gastroenterol Hepatol 2000; 12: 1077-88.
Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of travellers’ diarrhea by Lactobacillus GG. Ann Med 1990; 22: 53-56. http://dx.doi.org/10.3109/07853899009147242
Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Travel Med 1997; 4: 41-43. http://dx.doi.org/10.1111/j.1708-8305.1997.tb00772.x
Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001; 357: 1076-79. http://dx.doi.org/10.1016/S0140-6736(00)04259-8
Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109: 119-21. http://dx.doi.org/10.1067/mai.2002.120273
Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomized placebo-controlled trial. Lancet 2003; 361: 1869-71. http://dx.doi.org/10.1016/S0140-6736(03)13490-3
Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30: 1604-10. http://dx.doi.org/10.1046/j.1365-2222.2000.00943.x
Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99: 179-85. http://dx.doi.org/10.1016/S0091-6749(97)70093-9
Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 1995; 21: 224-26. http://dx.doi.org/10.1097/00005176-199508000-00016
Gorbach SL, Chang TW, Goldin BR. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; 2: 1519. http://dx.doi.org/10.1016/S0140-6736(87)92646-8
Bennett RG, Gorbach SL, Goldin BR, et al. Treatment of relapsing Clostridium difficile diarrhea with Lactobacillus GG. Nutr Today 1996; (Suppl 31): 35S-8S. http://dx.doi.org/10.1097/00017285-199508000-00016
Nase L, Hatakka K, Savilahti E, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res 2001; 35: 412-20.
Bruzzese E, Raia V, Gaudiello G, et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 2004; 20: 813-19. http://dx.doi.org/10.1111/j.1365-2036.2004.02174.x
Hatakka K, Savilahti E, Ponka A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centers: double blind, randomized trial. Br Med J 2001; 322: 1327. http://dx.doi.org/10.1136/bmj.322.7298.1327
Gluck U, Gebbers JO. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphyloccus aureus, Streptococcus pneumoniae, and b-hemolytic streptococci). Am J Clin Nutr 2003; 77: 517-20.
Mattila-Sandholm T, Blum S, Collins JK, et al. Probiotics: towards demonstrating efficacy. Trends Food Sci Technol 1999; 10: 393-99. http://dx.doi.org/10.1016/S0924-2244(00)00029-7
Malchow HA. Crohn’s disease and Escherichia coli: a new approach in therapy to maintain remission of colonic Crohn’s disease? J Clin Gastroenterol 1997; 25: 653-58. http://dx.doi.org/10.1097/00004836-199712000-00021
Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn’s disease. Dig Dis Sci 2000; 45: 1462-64.
Venturi A, Gionchetti P, Rizzello F, et al. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 1999; 13: 1103-8. http://dx.doi.org/10.1046/j.1365-2036.1999.00560.x
Brigdi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001; 152: 735-41. http://dx.doi.org/10.1016/S0923-2508(01)01254-2
Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2004; CD00304. http://dx.doi.org/10.1002/14651858.CD003048
Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomized placebo-controlled trials. Lancet Infect Dis 2006; 6: 374-82. http://dx.doi.org/10.1016/S1473-3099(06)70495-9
Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2007; 25: 155-68. http://dx.doi.org/10.1111/j.1365-2036.2006.03179.x
Gionchetti P, Lammers KM, Rizzello F, Campieri M. VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics. Gastroenterol Clin North Am 2005; 34: 499-513. http://dx.doi.org/10.1016/j.gtc.2005.05.003
Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotizing enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007; 369: 1614-20. http://dx.doi.org/10.1016/S0140-6736(07)60748-X
Hilliam M. Functional foods in Europe. World Ingred 1998; 7: 40-5.
Hollingsworth P. Mainstreaming healthy foods. Food Technol 1997; 51: 55-58.
Balaji RR, Kantha DA. Market potential for probiotic nutritional supplements in India. Afri J Busi Manag 2011; 5: 5418-23.
Stanton, Emms and Sia. Malaysia’s markets for functional foods, nutraceuticals and organic foods: an introduction for Canadian producers and exporters. March 2011. [Updated march 2011; Cited Nov 2012]. Available from: http://www.ats-sea.agr.gc.ca/ase/pdf/5842-eng.pdf
Food and Drug Administration. Overview of dietary supplements [updated Oct 2009; cited Nov 2012]. Available from: http://www.fda.gov/%20Food/DietarySupplements/ ConsumerInformation/ucm110417.htm
Food and Drug Administration. Federal Food, Drug, and Cosmetic Act (FD&C Act). 21 U.S.C. 321. Sect 201 (2004) [updated Oct 2009; Cited Dec 2012]. Available from: http://www.fda.gov/regulatoryinformation/legislation/federalfooddrugandcosmeticactfdcact/default.htm
Food and Drug Administration. Development & approval process (drugs) [updated Oct 2009; Cited Oct 2012]. Available from: http://www.fda.gov/Drugs/Development ApprovalProcess/default.htm
Food and Drug Administration. Guidance for Industry: CGMP for Phase 1 Investigational Drugs, July 2008. [Cited Nov 2012]. Available from: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM070273.htm
Dengan FH. Clinical studies involving probiotics. Gut microbes. 2012; 3: 485-89. http://dx.doi.org/10.4161/gmic.22158
Hoffman FA. Development of probiotics as biologic drugs. Clin Infect Dis. 2008; 46: 125-27. http://dx.doi.org/10.1086/523326
Heimbach JT. Health-benefit claims for probiotic products. Clin Infect Dis 2008; 46(2): 122-24. http://dx.doi.org/10.1086/523327
Food and Drug Administration. Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. 21 C.F.R.111 (2007). [Cited Nov 2012]. Available from: http://www.ahpa.org/ portals/0/pdfs/10_1216_21_cfr_111_small_entity_compliance.pdf
Agrawal A, Nagori BP, Mathur V. Regulatory approval of probiotics in US, Japan & India: A comparative study. Int J Sci Pharm Edu Res 2012; 2: 78-86.
Institute of Medicine of the National Academies. Regulating Pre- and Pro-biotics: a USFDA Perspective. [Cited Oct 2012]. Available from: www.iom.edu/~/media/.../Vaillancourt 17Mar05ProbioticsRegulationpdf
Thaindian News (November 2009). India to have guidelines for probiotic food by 2010. [updated 2009; Cited Dec 2012] Available from: http://www.thaindian.com/newsp probiotics/food_supplements/prw eb4494064.html
Guidelines for evaluation of probiotics in food. Report of a Joint ICMR/DBT 2011. [Cited Nov 2012]. Available from: http://icmr.nic.in/guide/PROBIOTICS_GUIDELINES.pdf
FAO/WHO. Guidelines for the evaluation of probiotics in food. 2002. [Cited Oct 2012]. Available from: http://www.who.int/foodsafety/fs_management/en/probiotic_ guidelines.pdf
FAO/WHO. Report of a joint FAO/WHO expert consultation on guidelines for the evaluation of probiotics in food. London, Ontario, Canada: World Health Organization and Food Agriculture Organization of the United Nations 2002.
Guarner F, Khan AG, Garisch J, et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol. 2012; 46(6): 468-81.
Guidelines and criteria for evaluation of efficacy, safety and health claim of probiotic in food products in India. ILSI, India. [Cited Sep 2012]. Available from: http://www.ilsi-india.org/PDF/Probiotic-in-Food-Products.pdf
Downloads
Published
How to Cite
Issue
Section
License
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:
- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .
